Visualizaciones | |
---|---|
Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial | 311 |
octubre 2023 | noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | |
---|---|---|---|---|---|---|---|
Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial | 0 | 2 | 2 | 5 | 0 | 4 | 1 |
Visualizaciones | |
---|---|
C1.2. Rossetti_Diabetes Technol Ther. 2012_ibolus for mealtime insulin dosing in T1DM.pdf.jpg | 428 |
C1.2. Rossetti_Diabetes Technol Ther. 2012_ibolus for mealtime insulin dosing in T1DM.pdf | 263 |
C1.2. Rossetti_Diabetes Technol Ther. 2012_ibolus for mealtime insulin dosing in T1DM.pdf.txt | 1 |
Visualizaciones | |
---|---|
Estados Unidos | 179 |
Francia | 30 |
España | 27 |
China | 25 |
Alemania | 17 |
Reino Unido | 4 |
Rusia | 4 |
Finlandia | 3 |
Suecia | 3 |
Taiwán | 3 |
Visualizaciones | |
---|---|
Ashburn | 34 |
Redmond | 23 |
Valencia | 16 |
Grenoble | 13 |
Mountain View | 13 |
Louisville | 11 |
Villeurbanne | 8 |
Beijing | 7 |
Alameda | 5 |
San Mateo | 4 |